Eli Lilly & Co. (NYSE: LLY) and Immunocore announced that they have entered into an immunotherapy-based clinical trial collaboration to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE